Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |